The Impact of COVID-19 is included in Gene Delivery Technologies Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Gene Delivery Technologies Trends and Forecast
The future of the global gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets. The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Gene Delivery Technologies by Segment
The study includes a forecast for the global gene delivery technologies by mode, method, application, and region.
Gene Delivery Technologies Market by Mode [Shipment Analysis by Value from 2018 to 2030]:
• Biological
• Chemical
• Physical
Gene Delivery Technologies Market by Method [Shipment Analysis by Value from 2018 to 2030]:
• Ex Vivo
• In Vivo
• In Vitro
Gene Delivery Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Gene Therapy
• Cell Therapy
• Vaccines
• Research
Gene Delivery Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Gene Delivery Technologies Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gene delivery technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene delivery technologies companies profiled in this report include-
• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys
Gene Delivery Technologies Market Insights
Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.
Within this market, gene therapy will remain the largest segment due to increasing adoption of gene-based therapies and growing number of clinical research initiatives.
North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.
Features of the Global Gene Delivery Technologies Market
Market Size Estimates: Gene delivery technologies market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Gene delivery technologies market size by mode, method, application, and region in terms of value ($B).
Regional Analysis: Gene delivery technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different modes, methods, applications, and regions for the gene delivery technologies market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene delivery technologies market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the gene delivery technologies market size?
Answer: The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030.
Q2. What is the growth forecast for gene delivery technologies market?
Answer: The global gene delivery technologies market is expected to grow with a CAGR of 14.6% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the gene delivery technologies market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.
Q4. What are the major segments for gene delivery technologies market?
Answer: The future of the gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets.
Q5. Who are the key gene delivery technologies market companies?
Answer: Some of the key gene delivery technologies companies are as follows:
• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys
Q6. Which gene delivery technologies market segment will be the largest in future?
Answer: Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.
Q7. In gene delivery technologies market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the gene delivery technologies market by mode (biological, chemical, and physical), method (ex vivo, in vivo, and in vitro), application (gene therapy, cell therapy, vaccines, and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Gene Delivery Technologies Market, Gene Delivery Technologies Market Size, Gene Delivery Technologies Market Growth, Gene Delivery Technologies Market Analysis, Gene Delivery Technologies Market Report, Gene Delivery Technologies Market Share, Gene Delivery Technologies Market Trends, Gene Delivery Technologies Market Forecast, Gene Delivery Technologies Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Gene Delivery Technologies Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Gene Delivery Technologies Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Gene Delivery Technologies Market by Mode
3.3.1: Biological
3.3.2: Chemical
3.3.3: Physical
3.4: Global Gene Delivery Technologies Market by Method
3.4.1: Ex vivo
3.4.2: In vivo
3.4.3: In vitro
3.5: Global Gene Delivery Technologies Market by Application
3.5.1: Gene Therapy
3.5.2: Cell Therapy
3.5.3: Vaccines
3.5.4: Research
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Gene Delivery Technologies Market by Region
4.2: North American Gene Delivery Technologies Market
4.2.2: North American Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
4.3: European Gene Delivery Technologies Market
4.3.1: European Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
4.3.2: European Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
4.4: APAC Gene Delivery Technologies Market
4.4.1: APAC Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
4.4.2: APAC Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
4.5: ROW Gene Delivery Technologies Market
4.5.1: ROW Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
4.5.2: ROW Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Gene Delivery Technologies Market by Mode
6.1.2: Growth Opportunities for the Global Gene Delivery Technologies Market by Method
6.1.3: Growth Opportunities for the Global Gene Delivery Technologies Market by Application
6.1.4: Growth Opportunities for the Global Gene Delivery Technologies Market by Region
6.2: Emerging Trends in the Global Gene Delivery Technologies Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Gene Delivery Technologies Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Delivery Technologies Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: QIAGEN
7.3: Horizon Discovery
7.4: OriGene Technologies
7.5: Oxford Biomedica
7.6: SignaGen Laboratories
7.7: Vectalys
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Gene Delivery Technologies Market Report.